Congress Asset Management Co. raised its stake in Balchem Co. (NASDAQ:BCPC – Free Report) by 5.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 317,610 shares of the basic materials company’s stock after buying an additional 16,170 shares during the quarter. Congress Asset Management Co.’s holdings in Balchem were worth $51,769,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in BCPC. Westside Investment Management Inc. purchased a new position in shares of Balchem in the 3rd quarter worth approximately $27,000. R Squared Ltd purchased a new position in Balchem in the fourth quarter worth $29,000. nVerses Capital LLC acquired a new position in shares of Balchem during the third quarter worth $35,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Balchem during the 3rd quarter valued at $35,000. Finally, Blue Trust Inc. boosted its position in shares of Balchem by 642.5% in the 3rd quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock worth $148,000 after purchasing an additional 726 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors.
Balchem Price Performance
Shares of BCPC opened at $164.82 on Friday. The firm has a market capitalization of $5.36 billion, a PE ratio of 44.31, a price-to-earnings-growth ratio of 4.42 and a beta of 0.69. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. The company’s fifty day moving average price is $163.46 and its 200-day moving average price is $169.59. Balchem Co. has a 1-year low of $137.69 and a 1-year high of $186.03.
Balchem Increases Dividend
Analyst Ratings Changes
A number of research firms have commented on BCPC. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright increased their price objective on shares of Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, November 4th.
View Our Latest Analysis on BCPC
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Recommended Stories
- Five stocks we like better than Balchem
- Investing in Travel Stocks Benefits
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- What is a Death Cross in Stocks?
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- Are Penny Stocks a Good Fit for Your Portfolio?
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.